We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Advances in Phenotypic Screening: A Turning Point for Drug Discovery?

Article   Jul 14, 2020 | By Michele Wilson, PhD

 
Advances in Phenotypic Screening: A Turning Point for Drug Discovery?

Human colorectal cancer cells treated with a topoisomerase inhibitor and an inhibitor of the protein kinase ATR. Cell nuclei (blue), DNA damage (red), foci of DNA replication (green). Credit: Yves Pommier, Rozenn Josse, NCI Center for Cancer Research.

 
 
Advertisement
 

RELATED ARTICLES

The Challenges of Analytical Chromatography We Can Leave in the Past

Article

Determining low levels of ionic impurities no longer needs to be slow and complicated, as modern and optimized instruments are available to simplify and expedite analysis. In this article, we use real-life examples to showcase ion chromatography as an efficient and sensitive method that helps to overcome analytical challenges.

READ MORE

Building Better Cell Lines

Article

Scientists have access to several approaches for developing cell lines. Whilst some tried and true methods have fallen by the wayside with the adoption of newer technologies, many older protocols are still in use alongside next-generation methods.

READ MORE

Stay Up-to-Date With COVID-19 Drug Development

Article

Whilst the world waits for an effective COVID-19 vaccine to be developed, researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE